Harbor Investment Advisory, LLC Intercept Pharmaceuticals, Inc. Transaction History

Harbor Investment Advisory, LLC

  • $1.19 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
BUY
$24.48 - $42.47 $4,381 - $7,602
179 Added 45.55%
572 $14,000
Q3 2020

Oct 23, 2020
BUY
$39.09 - $53.44 $7,622 - $10,420
195 Added 98.48%
393 $16,000
Q1 2020

May 11, 2020
BUY
$48.35 - $118.68 $9,573 - $23,498
198 New
198 $12,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email